Troglitazone
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Anaemia | postmarketing | x | |
| Oedema | postmarketing | x | |
| Body temperature increased | postmarketing | x | |
| Cardiac failure congestive | postmarketing | x | |
| Hyperglycaemia | postmarketing | x | |
| Syncope | postmarketing | x | |
| Weight increased | postmarketing | x | |
| Malaise | postmarketing | x | |
| Laboratory test abnormal | postmarketing | x | |
| Abdominal pain | x | ||
| Anorexia | x | ||
| Fatigue | x | ||
| Hepatitis | x | ||
| Jaundice | x | ||
| Nausea | x | ||
| Vomiting | x | ||
| Hepatic function abnormal | x | ||
| Liver function test abnormal | x | ||
| Alanine aminotransferase increased | x | ||
| Volume plasma increased | x | ||
| Idiosyncratic drug reaction | x | ||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Type 2 diabetes mellitus | x | ||
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
